XML 22 R8.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net loss $ (157,803) $ (100,048) $ (46,514)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization of fixed assets 7,600 3,710 1,418
Loss on disposal of property and equipment 40 49 100
Stock-based compensation 18,050 11,520 7,744
Amortization of deferred license fees   (294) (4,144)
Amortization of other liabilities (573)    
Amortization of deferred financing costs 44    
Forgiveness of long-term debt (1,000)    
Amortization of premium on short-term investments 1,323 842 636
Amortization of intangible assets 150    
Changes in assets and liabilities:      
Accounts receivable (3,557) (1,376)  
Inventory, net (2,660) (4,017)  
Prepaid expenses and other current assets (3,057) (1,329) (1,606)
Accounts payable 661 1,886 (2,891)
Accrued liabilities 7,424 8,064 2,299
Lease incentive obligation (553) (487) 2,655
Accrued interest (106) 22 21
Net cash used in operating activities (134,017) (81,458) (40,282)
Cash flows from investing activities:      
Purchases of marketable securities (205,054) (209,471) (98,510)
Maturities of marketable securities 162,283 104,172 72,289
Purchases of property and equipment (20,084) (11,991) (8,748)
Purchases of intangible assets (1,900)    
Net cash used in investing activities (64,755) (117,290) (34,969)
Cash flows from financing activities:      
Proceeds from exercise of common stock options 1,248 2,640 1,341
Proceeds from sale of common stock, net of issuance costs 174,140 238,580 73,296
Payments on capital lease obligations (360) (351) (333)
Payments on mortgage payable (44)    
Proceeds from mortgage payable 5,062    
Proceeds from New Market Tax Credit financing agreements   2,399  
Proceeds in connection with the Company's employee stock purchase plan 1,719 760 453
Net cash provided by financing activities 181,765 244,028 74,757
Effects of exchange rate on cash and cash equivalents 11    
Net (decrease) increase in cash and cash equivalents (16,996) 45,280 (494)
Cash and cash equivalents, beginning of period 58,131 12,851 13,345
Cash and cash equivalents, end of period 41,135 58,131 12,851
Supplemental disclosure of non-cash investing and financing activities:      
Property and equipment acquired but not paid 1,705 546 534
Unrealized gain on available-for-sale investments (329) (240) 47
Issuance of 21,826 and 32,669 shares of common stock to fund the Company’s 401(k) matching contribution for 2015 and 2014, respectively 836 456 354
Interest paid $ 95 $ 29 $ 48